Clawback Provision

A clawback provision is a legal covenant requiring the general partner to surrender previously distributed carried interest to the fund if cumulative LP returns fall below agreed targets by the fund’s final liquidation. Rather than allowing the GP to keep excess carried interest from early successful exits, the clawback sets the LP return as the ultimate measure and forces the GP to reimburse if later-stage losses or poor performance wipe out those early gains.

Why clawbacks exist (and why GPs hate them)

Early-stage exits can generate extraordinary carried interest. Suppose a fund buys a company in year 1, sells it successfully in year 3, and distributes 25% carry to the GP. The GP pockets millions and moves on to the next fund.

But the fund still has five more years to run. The remaining portfolio companies stumble. A few default; others generate mediocre returns. By final liquidation in year 10, the cumulative fund return to LPs falls short of the agreed hurdle. The GP has already spent the carry from the early exit.

A clawback clause makes this a problem: the GP must return that distributed carry, either from reserves or out of pocket. This aligns the GP’s incentives with the entire fund lifecycle, not just early exits. No more exit-and-run.

From the LP perspective, the clawback is essential risk management. Without it, a GP has every incentive to cherry-pick winners early, take carry, and leave the LP holding the losing portfolio through the end of the fund. With the clawback, the GP’s carried interest is conditional on the full fund’s success.

How clawback mechanics work

Most clawback provisions follow a standardized calculation:

1. Define the hurdle: Usually the preferred return hurdle, often 8% or 9% per annum. Some funds use a pure cash-return multiple (e.g., 1.5× LP money).

2. Track distributions: As the fund makes distributions to GPs (as carry), the GP’s carry account is tracked separately. The LP’s account and GP’s account are always reconciled.

3. Final settlement: At final liquidation, the GP’s total distributions are compared to its “fair carry” based on actual LP returns. If the GP took more than it earned, the excess is clawed back.

4. Payment: The GP remits the clawed-back amount within 90–180 days. Many GPs reserve a percentage of carry (typically 10–20%) in an escrow account specifically to cover clawbacks, reducing the risk of personal bankruptcy claims.

The math is straightforward but can be contentious. If the hurdle is 8% and LPs achieved 7%, the entire carry pool may be clawed back. If LPs achieved 12%, the GP keeps more carry. The exact calculation depends on waterfall structure, fee offsets, and expense treatment—details that can spark disputes.

Why clawbacks are rare in practice

Despite their contractual frequency, actual clawback events are surprisingly uncommon. Most funds that underperform are closed by GP default, bankruptcy, or settlement long before final liquidation. Clawback litigation is expensive and recoverable assets are often depleted.

Additionally, fundraising dynamics discourage clawbacks. A GP with a history of clawed-back carry becomes a pariah for LPs and finds it nearly impossible to raise the next fund. So even though the contract permits clawbacks, GPs often negotiate settlement or wind-down without triggering them.

In strong market cycles (2005–2007, 2013–2019), clawbacks almost never occur because most funds perform well. In tough cycles (2008–2011, 2022–2024), clawbacks are more likely—but even then, many are settled outside the formal process.

Clawback funding and the GP’s skin in the game

To manage clawback risk, mature GPs reserve a portion of distributed carry in an escrow account. For a $100 million carry distribution in a strong year, the GP might receive only $80 million directly and hold $20 million in escrow for two to three years. If no clawback is triggered, that escrow is released. If a clawback occurs, the escrow absorbs the hit first.

This escrow structure incentivizes the GP to be realistic about portfolio valuations and not take excess carry too early. It also provides LPs with a faster, more reliable clawback source than pursuing the GP personally.

Some GPs also maintain “clawback insurance”—a specialized policy that covers the GP’s contingent liability. These policies are uncommon and expensive, so only the largest or most risk-averse GPs purchase them.

Variations and negotiation

Clawback terms are heavily negotiated:

• Threshold: Some clauses have a floor (e.g., no clawback unless the shortfall exceeds $10 million), reducing disputes over minor shortfalls.
• Offset for fees: Should the clawback calculation offset management fees already paid to the GP? Most do.
• Carry-forward losses: In multi-fund complexes, do losses in Fund II clawed back against carry in Fund III? Rarely, but occasionally structured this way.
• Dollar cap: Some LPs and GPs negotiate a maximum clawback (e.g., 50% of total carry paid), capping the GP’s downside.

Large institutional LPs (endowments, pension funds) push for aggressive clawback terms. Smaller funds with tight LP bases sometimes negotiate softer triggers to avoid alienating their investor base.

The strategic incentive effect

Clawbacks theoretically discourage excessive risk-taking by the GP in early years. If the GP knows that early gains can be clawed back, it may be more disciplined about valuation timing and not oversell winners too early.

In practice, this effect is weaker than the theory suggests. GPs still face pressure from LPs to “show performance” early, and they know that clawbacks are rare in practice. So the deterrent effect exists but is modest.

The real discipline comes from GP reputation and the next fund raise. A fund with significant clawbacks finds its AUM growth stunted and limited partner commitments harder to secure.

See also